{"filing":{"accession_number":"0001493152-26-040814","cik":"0001326706","ticker":"FEED","company_name":"ENvue Medical, Inc.","form":"8-K","filing_date":"2026-08-31","report_date":"2026-08-28","primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1326706/000149315226040814/form8-k.htm"},"events":[{"id":30585,"run_id":28034,"accession_number":"0001493152-26-040814","anchor_item_number":null,"event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.85,"summary":"The filing discloses a 1-for-12 reverse stock split approved by shareholders on August 14, 2026 and effective September 1, 2026, reducing outstanding shares from 11,084,616 to approximately 923,718. While reverse splits are governance/capital structure events, this one is material to investors as it affects share price, trading mechanics, and may signal financial distress or delisting concerns typical of reverse-split companies. The event is clearly governance-related (shareholder-approved amendment to capitalization) but does not fit the specific categories of exec_appointment, exec_departure, exec_compensation, or shareholder_vote_results (which would apply only if the filing disclosed the vote results themselves rather than just the approved action).","company_name":"ENvue Medical, Inc.","ticker":"FEED","filing_date":"2026-08-31","form":"8-K","submitted_at":null,"items":null}],"classifications":[{"id":33219,"accession_number":"0001493152-26-040814","item_number":null,"item_title":null,"event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.85,"reasoning":"The filing discloses a 1-for-12 reverse stock split approved by shareholders on August 14, 2026 and effective September 1, 2026, reducing outstanding shares from 11,084,616 to approximately 923,718. While reverse splits are governance/capital structure events, this one is material to investors as it affects share price, trading mechanics, and may signal financial distress or delisting concerns typical of reverse-split companies. The event is clearly governance-related (shareholder-approved amendment to capitalization) but does not fit the specific categories of exec_appointment, exec_departure, exec_compensation, or shareholder_vote_results (which would apply only if the filing disclosed the vote results themselves rather than just the approved action).","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-31T20:03:19.328360+00:00","company_name":"ENvue Medical, Inc.","ticker":"FEED","filing_date":"2026-08-31"}]}